Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
2-oxoglutarate and iron-dependent oxygenase domain-containing protein 3 (OGFOD3) is a membrane-associated enzyme with predicted 2-oxoglutarate-dependent dioxygenase activity, iron ion binding, and L-ascorbic acid binding capacity. OGFOD3 belongs to a family of enzymes involved in oxidation–reduction processes that use iron and 2-oxoglutarate as cofactors. It is a protein-coding gene found mainly in animals, with orthologs observed in mammals and invertebrates. Despite being well-characterized at the sequence and domain level, the exact physiological substrates and biological roles of OGFOD3 remain largely uncharacterized. Association with disease has been suggested through genetic studies linking it to mixed receptive-expressive language disorder and chromosome 17q12 duplication syndrome. Gene fusion events involving OGFOD3 (e.g., OGFOD3-WDR45B) have been observed in some cancers, but its direct pathogenic or therapeutic relevance is undetermined and not currently a focus of targeted drug development.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 2-oxoglutarate and iron-dependent oxygenase domain-containing protein 3 (OGFOD3).